title: Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells.
abstract: Verotoxin (VT) has been implicated in the promotion of adherence to and colonization of intestinal epithelial cells by enterohemorrhagic Escherichia coli (EHEC) O157:H7. The present study investigated the effect of VT2 on the adherence of EHEC O157:H7 strain 86-24 to porcine jejunal (IPEC-J2), human colon (CaCo-2), and human laryngeal carcinoma (HEp-2) cell lines and on the expression in IPEC-J2 cells of synthases for beta1-integrin and nucleolin, both of which are implicated in bacterial adherence. The effect on expression of globotriaosylceramide (Gb3) synthase, the receptor for VT, was also examined. Data were obtained by adherence assays and quantitative reverse transcriptase PCR, using EHEC O157 strain 86-24, a vt2 deletion mutant, a vt2 phage-negative strain, and complemented mutants in which the vt2 gene was restored. Compared with the adherence of the parent and complemented mutant strains, the vt2-negative strains adhered significantly less to all three types of cells. Adherence of the wild-type EHEC strain to IPEC-J2 cells was accompanied by increased expression of beta1-integrin, nucleolin, and Gb3 synthase. IPEC-J2 cells in association with wild-type EHEC O157:H7 or the complemented mutants expressed higher levels of beta1-integrin than did cells in association with the vt2-negative strains or with no bacteria. Expression of nucleolin was decreased by association with the vt2-negative mutant, but complementation failed to restore wild-type expression. The data indicate that VT2 plays a role in the adherence of EHEC O157:H7 to intestinal epithelial cells, possibly by increasing the expression of the host receptor beta1-integrin.
authors.affiliation: Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada N1G 2W1.
authors.forename: Bianfang
authors.initials: B
authors.lastname: Liu
authors.forename: Xianhua
authors.initials: X
authors.lastname: Yin
authors.forename: Yanni
authors.initials: Y
authors.lastname: Feng
authors.forename: James R
authors.initials: JR
authors.lastname: Chambers
authors.forename: Aiguang
authors.initials: A
authors.lastname: Guo
authors.forename: Joshua
authors.initials: J
authors.lastname: Gong
authors.forename: Jing
authors.initials: J
authors.lastname: Zhu
authors.forename: Carlton L
authors.initials: CL
authors.lastname: Gyles
mesh_terms: D000818:Animals; D001422:Bacterial Adhesion / Q000187:drug effects*; D002460:Cell Line; D045744:Cell Line, Tumor; D003106:Colon / Q000166:cytology / Q000382:microbiology; D004847:Epithelial Cells / Q000166:cytology / Q000382:microbiology*; D019453:Escherichia coli O157 / Q000378:metabolism / Q000502:physiology*; D005700:Galactosyltransferases / Q000378:metabolism; D006801:Humans; D019012:Integrin beta1 / Q000378:metabolism; D007583:Jejunum / Q000166:cytology / Q000382:microbiology*; D010750:Phosphoproteins / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000378:metabolism; D022641:Shiga Toxin 2 / Q000378:metabolism* / Q000494:pharmacology; D013552:Swine; D000097796:Nucleolin
chemical_list: D005700:Galactosyltransferases; D019012:Integrin beta1; D010750:Phosphoproteins; D016601:RNA-Binding Proteins; D022641:Shiga Toxin 2; D000097796:Nucleolin; C045097:UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferase
references.citation: Infect Immun. 1991 Nov;59(11):4173-9
references.pmid: 1937774
references.citation: Infect Immun. 2003 Dec;71(12):7129-39
references.pmid: 14638803
references.citation: Appl Environ Microbiol. 2009 Aug;75(15):4975-83
references.pmid: 19525268
references.citation: Nat Rev Microbiol. 2004 Feb;2(2):123-40
references.pmid: 15040260
references.citation: Nature. 2001 Jan 25;409(6819):529-33
references.pmid: 11206551
references.citation: Mol Microbiol. 1998 Dec;30(5):911-21
references.pmid: 9988469
references.citation: J Am Soc Nephrol. 2002 Sep;13(9):2239-45
references.pmid: 12191968
references.citation: Nat Rev Microbiol. 2010 Feb;8(2):105-16
references.pmid: 20023663
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4535-6
references.pmid: 18353979
references.citation: Lancet. 2005 Mar 19-25;365(9464):1073-86
references.pmid: 15781103
references.citation: Infect Immun. 2006 Aug;74(8):4685-93
references.pmid: 16861656
references.citation: J Biol Chem. 2000 May 19;275(20):15152-6
references.pmid: 10748143
references.citation: Clin Vaccine Immunol. 2006 Dec;13(12):1322-7
references.pmid: 17050743
references.citation: Kidney Int. 2000 Jun;57(6):2650-1
references.pmid: 10844636
references.citation: J Biol Chem. 2004 Aug 6;279(32):33751-8
references.pmid: 15173179
references.citation: Biotechniques. 1993 Nov;15(5):831-4
references.pmid: 8267974
references.citation: Crit Rev Microbiol. 2003;29(4):277-96
references.pmid: 14636040
references.citation: Mol Microbiol. 1999 Sep;33(6):1176-89
references.pmid: 10510232
references.citation: BMC Mol Biol. 2003 Dec 13;4:11
references.pmid: 14672541
references.citation: Appl Environ Microbiol. 2007 Jan;73(1):344-6
references.pmid: 17085690
references.citation: Infect Immun. 2008 Nov;76(11):4814-22
references.pmid: 18725421
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9667-72
references.pmid: 16766659
references.citation: J Biol Chem. 1996 Aug 23;271(34):20359-64
references.pmid: 8702771
references.citation: J Infect Dis. 1989 Feb;159(2):344-7
references.pmid: 2644374
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Microbes Infect. 2007 Jan;9(1):35-9
references.pmid: 17208032
references.citation: Vet Microbiol. 2003 May 29;93(3):207-22
references.pmid: 12695045
references.citation: Cell. 1992 Apr 3;69(1):11-25
references.pmid: 1555235
references.citation: Infect Immun. 2006 Feb;74(2):1255-65
references.pmid: 16428775
references.citation: Trends Microbiol. 2001 May;9(5):214-8
references.pmid: 11336837